Ivan Cecconello

Ivan Cecconello

Auto-generated profile, based on publicly available information

Ivan Cecconello

Faculdade de Medicina do Hospital das Clínicas da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Annals of Surgery
Verified
Journal Article
Closed access
DLDonald E Low
Donald E Low
DADerek Alderson
Derek Alderson
ICIvan Cecconello
Ivan Cecconello
ACAndrew C. Chang
Andrew C. Chang
GDGail E. Darling
Gail E. Darling
JLJ. Jan B. van Lanschot
J. Jan B. van Lanschot
Perioperative complications influence long- and short-term outcomes after esophagectomy. The absence of a standardized system for defining and recording complications and quality measures after esophageal resection has meant that there is wide variation in evaluating their impact on these outcomes. The Esophageal Complications Consensus Group comprised 21 high-volume esophageal surgeons from 14 countries, supported by all the major thoracic and upper gastrointestinal professional societies. Delphi surveys and group meetings were used to achieve a consensus on standardized methods for defining complications and quality measures that could be collected in institutional databases and national audits. A standardized list of complications was created to provide a template for recording individual complications associated with esophagectomy. Where possible, these were linked to preexisting international definitions. A Delphi survey facilitated production of specific definitions for anastomotic leak, conduit necrosis, chyle leak, and recurrent nerve palsy. An additional Delphi survey documented consensus regarding critical quality parameters recommended for routine inclusion in databases. These quality parameters were documentation on mortality, comorbidities, completeness of data collection, blood transfusion, grading of complication severity, changes in level of care, discharge location, and readmission rates. The proposed system for defining and recording perioperative complications associated with esophagectomy provides an infrastructure to standardize international data collection and facilitate future comparative studies and quality improvement projects.

4 October 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ABAdam J Bass
Adam J Bass
HWHideo Watanabe
Hideo Watanabe
CMCraig H Mermel
Craig H Mermel
SYSoyoung Yu
Soyoung Yu
SPSven Perner
Sven Perner
MMMatthew Meyerson
Matthew Meyerson
Matthew Meyerson and colleagues report that SOX2, which encodes a transcription factor necessary for normal esophageal development, is an amplified lineage survival oncogene in lung and esophageal squamous cell carcinomas. Lineage-survival oncogenes are activated by somatic DNA alterations in cancers arising from the cell lineages in which these genes play a role in normal development1,2. Here we show that a peak of genomic amplification on chromosome 3q26.33 found in squamous cell carcinomas (SCCs) of the lung and esophagus contains the transcription factor gene SOX2, which is mutated in hereditary human esophageal malformations3, is necessary for normal esophageal squamous development4, promotes differentiation and proliferation of basal tracheal cells5 and cooperates in induction of pluripotent stem cells6,7,8. SOX2 expression is required for proliferation and anchorage-independent growth of lung and esophageal cell lines, as shown by RNA interference experiments. Furthermore, ectopic expression of SOX2 here cooperated with FOXE1 or FGFR2 to transform immortalized tracheobronchial epithelial cells. SOX2-driven tumors show expression of markers of both squamous differentiation and pluripotency. These characteristics identify SOX2 as a lineage-survival oncogene in lung and esophageal SCC.

1 February 2019 in Annals of Surgery
Verified
Journal Article
Closed access
PDF file
DLDonald E Low
Donald E Low
MKMadhan Kumar Kuppusamy
Madhan Kumar Kuppusamy
DADerek Alderson
Derek Alderson
ICIvan Cecconello
Ivan Cecconello
ACAndrew C. Chang
Andrew C. Chang
BWB. P. L. Wijnhoven
B. P. L. Wijnhoven
Objective: Utilizing a standardized dataset with specific definitions to prospectively collect international data to provide a benchmark for complications and outcomes associated with esophagectomy. Summary of Background Data: Outcome reporting in oncologic surgery has suffered from the lack of a standardized system for reporting operative results particularly complications. This is particularly the case for esophagectomy affecting the accuracy and relevance of international outcome assessments, clinical trial results, and quality improvement projects. Methods: The Esophageal Complications Consensus Group (ECCG) involving 24 high-volume esophageal surgical centers in 14 countries developed a standardized platform for recording complications and quality measures associated with esophagectomy. Using a secure online database (ESODATA.org), ECCG centers prospectively recorded data on all resections according to the ECCG platform from these centers over a 2-year period. Results: Between January 2015 and December 2016, 2704 resections were entered into the database. All demographic and follow-up data fields were 100% complete. The majority of operations were for cancer (95.6%) and typically located in the distal esophagus (56.2%). Some 1192 patients received neoadjuvant chemoradiation (46.1%) and 763 neoadjuvant chemotherapy (29.5%). Surgical approach involved open procedures in 52.1% and minimally invasive operations in 47.9%. Chest anastomoses were done most commonly (60.7%) and R0 resections were accomplished in 93.4% of patients. The overall incidence of complications was 59% with the most common individual complications being pneumonia (14.6%) and atrial dysrhythmia (14.5%). Anastomotic leak, conduit necrosis, chyle leaks, recurrent nerve injury occurred in 11.4%, 1.3%, 4.7%, and 4.2% of cases, respectively. Clavien-Dindo complications ≥ IIIb occurred in 17.2% of patients. Readmissions occurred in 11.2% of cases and 30- and 90-day mortality was 2.4% and 4.5%, respectively. Conclusion: Standardized methods provide contemporary international benchmarks for reporting outcomes after esophagectomy.

20 March 2007 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
SBSilvio Balzan
Silvio Balzan
CQClaudio De Almeida Quadros
Claudio De Almeida Quadros
RCRoberto De Cleva
Roberto De Cleva
BZBruno Zilberstein
Bruno Zilberstein
ICIvan Cecconello
Ivan Cecconello

30 August 2018 in Diseases of the Esophagus
Verified
Journal Article
Open access
PDF file
GZG Zaninotto
G Zaninotto
CBC Bennett
C Bennett
GBG Boeckxstaens
G Boeckxstaens
MCM Costantini
M Costantini
MFM K Ferguson
M K Ferguson
DLDonald E Low
Donald E Low
Achalasia is a relatively rare primary motor esophageal disorder, characterized by absence of relaxations of the lower esophageal sphincter and of peristalsis along the esophageal body. As a result, patients typically present with dysphagia, regurgitation and occasionally chest pain, pulmonary complication and malnutrition. New diagnostic methodologies and therapeutic techniques have been recently added to the armamentarium for treating achalasia. With the aim to offer clinicians and patients an up-to-date framework for making informed decisions on the management of this disease, the International Society for Diseases of the Esophagus Guidelines proposed and endorsed the Esophageal Achalasia Guidelines (I-GOAL). The guidelines were prepared according the Appraisal of Guidelines for Research and Evaluation (AGREE-REX) tool, accredited for guideline production by NICE UK. A systematic literature search was performed and the quality of evidence and the strength of recommendations were graded according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Given the relative rarity of this disease and the paucity of high-level evidence in the literature, this process was integrated with a three-step process of anonymous voting on each statement (DELPHI). Only statements with an approval rate >80% were accepted in the guidelines. Fifty-one experts from 11 countries and 3 representatives from patient support associations participated to the preparations of the guidelines. These guidelines deal specifically with the following achalasia issues: Diagnostic workup, Definition of the disease, Severity of presentation, Medical treatment, Botulinum Toxin injection, Pneumatic dilatation, POEM, Other endoscopic treatments, Laparoscopic myotomy, Definition of recurrence, Follow up and risk of cancer, Management of end stage achalasia, Treatment options for failure, Achalasia in children, Achalasia secondary to Chagas' disease.

1 July 2008 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
AHAngelita Habr-Gama
Angelita Habr-Gama
RPRodrigo Oliva Perez
Rodrigo Oliva Perez
IPIgor Proscurshim
Igor Proscurshim
RSRafael Miyashiro Nunes dos Santos
Rafael Miyashiro Nunes dos Santos
DKDesiderio Kiss
Desiderio Kiss
ICIvan Cecconello
Ivan Cecconello